Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Neuroscience|December 25, 2014
The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseasesSahar Al-Mahdawi, Sara Anjomani Virmouni, Mark A Pook
Scientific Reports|April 30, 2025
Galleria mellonella as a drug discovery model to study oxidative stressFred Jonathan Edzeamey, Zenouska Ramchunder, Ronan R McCarthy, et al.
Molecular & Cellular Oncology|December 7, 2017
PARK2 loss promotes cancer progression via redox-mediated inactivation of PTENAmit Gupta, Sara Anjomani-Virmouni, Nikos Koundouros, et al.
Frontiers in Pharmacology|February 21, 2024
Emerging antioxidant therapies in Friedreich's ataxiaFred Jonathan Edzeamey, Zenouska Ramchunder, Charareh Pourzand, et al.
Genes, Chromosomes & Cancer|June 14, 2016
Analysis of alternative lengthening of telomere markers in BRCA1 defective cellsParisa K Kargaran, Hemad Yasaei, Sara Anjomani-Virmouni, et al.
Breast Cancer Research and Treatment|May 9, 2014
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell linesAzadeh Motevalli, Hemad Yasaei, Sara Anjomani Virmouni, et al.
Plos One|September 9, 2014
Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxiaSara Anjomani Virmouni, Chiranjeevi Sandi, Sahar Al-Mahdawi, et al.
Drug Discovery Today|March 18, 2026
Deciphering the missing links between Friedreich ataxia and multiple sclerosis for targeted drug developmentFaith A A Kwa, Sara Anjomani-Virmouni, Zenouska Ramchunder, et al.
Frontiers in Genetics|June 12, 2014
Epigenetic-based therapies for Friedreich ataxiaChiranjeevi Sandi, Madhavi Sandi, Sara Anjomani Virmouni, et al.
Plos One|June 28, 2014
MutLα heterodimers modify the molecular phenotype of Friedreich ataxiaVahid Ezzatizadeh, Chiranjeevi Sandi, Madhavi Sandi, et al.
Pageof 3